{"schema_version":"1","generated_at":"2026-11-21T02:16:33.522Z","data_as_of":"2026-11-09","url":"https://www.findmykol.com/kol/naomi-fisher","json_url":"https://www.findmykol.com/kol/naomi-fisher/profile.json","record_kind":"full","profile_kind":"clinical","person":{"slug":"naomi-fisher","name":"Naomi Fisher","credential":"MD","title":"Director of hypertension services and hypertension innovation","specialty":"Endocrinology, Diabetes & Metabolism","specialty_raw":"Endocrinology, Diabetes & Metabolism","therapeutic_area":"Epidemiology","therapeutic_areas":["Epidemiology","Endocrinology/Metabolic"],"institution":"Brigham and Women's Hospital","institution_url":"https://www.findmykol.com/institution/brigham-and-women-s-hospital","city":"Boston","state":"MA","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"},"country":{"name":"United States","code":"US","status":"verified"}},"identifiers":{"on_file":["npi","orcid","openalex"],"values":"Shown on the profile page to a signed-in account."},"summary":"Naomi Fisher is Director of hypertension services and hypertension innovation at Brigham and Women's Hospital. OpenAlex indexes 187 publications with 8,351 citations (h-index 51); ClinicalTrials.gov lists 6 registered studies with this person as an investigator.","overview":{"text":"Naomi Fisher, MD, is Director of hypertension services and hypertension innovation at Brigham and Women's Hospital. The public record shows 187 publications with 8,351 citations (h-index 51), centered on Blood Pressure and Hypertension Studies, Renin-Angiotensin System Studies, Cardiovascular Health and Disease Prevention. It also documents an investigator role on 6 registered clinical trials, industry payments reported by 7 companies, 6 NIH-funded awards (1998–2012).","bullets":["Most recent indexed publication: 2026 · Hypertension (Dallas, Tex.","Top research focus: Blood Pressure and Hypertension Studies","6 registered trials on ClinicalTrials.gov","Open Payments reporting from 7 companies"],"generated_at":"2026-11-20"},"focus":{"indications":[{"label":"Hypertension","therapeutic_area":"Cardiology","trials":6,"topics":0,"strength":19},{"label":"Cardiovascular Diseases","therapeutic_area":"Cardiology","trials":2,"topics":0,"strength":6},{"label":"Vascular Diseases","therapeutic_area":"Cardiology","trials":2,"topics":0,"strength":6},{"label":"Acromegaly","therapeutic_area":"Endocrinology/Metabolic","trials":0,"topics":0,"strength":1},{"label":"Alzheimer's / Dementia","therapeutic_area":"Neurology","trials":0,"topics":0,"strength":1},{"label":"Atrial Fibrillation","therapeutic_area":"Cardiology","trials":0,"topics":0,"strength":1},{"label":"Chronic Kidney Disease","therapeutic_area":"Nephrology","trials":0,"topics":0,"strength":1},{"label":"Coronary Artery Disease / ACS","therapeutic_area":"Cardiology","trials":0,"topics":0,"strength":1},{"label":"COVID-19","therapeutic_area":"Infectious Disease","trials":0,"topics":0,"strength":1},{"label":"Cushing's Syndrome","therapeutic_area":"Endocrinology/Metabolic","trials":0,"topics":0,"strength":1},{"label":"Dyslipidemia / Lipid Disorders","therapeutic_area":"Cardiology","trials":0,"topics":0,"strength":1},{"label":"Gout","therapeutic_area":"Rheumatology/Immunology","trials":0,"topics":0,"strength":1},{"label":"Heart Failure","therapeutic_area":"Cardiology","trials":0,"topics":0,"strength":1},{"label":"Obesity","therapeutic_area":"Endocrinology/Metabolic","trials":0,"topics":0,"strength":1},{"label":"Substance Use Disorders","therapeutic_area":"Psychiatry","trials":0,"topics":0,"strength":1},{"label":"Type 2 Diabetes","therapeutic_area":"Endocrinology/Metabolic","trials":0,"topics":0,"strength":1}],"research_topics":["Blood Pressure and Hypertension Studies","Renin-Angiotensin System Studies","Cardiovascular Health and Disease Prevention","Hormonal Regulation and Hypertension","Renal and Vascular Pathologies"],"drugs_studied":{"total":1,"shown":1,"withheld":0,"rows":[{"name":"Xarelto","generic":"Rivaroxaban","trials":0,"payments":1,"publications":0,"mentions":1}]},"works_with":{"total":9,"shown":3,"withheld":6,"rows":[{"name":"ReCor Medical, Inc.","trials":2,"payments":22,"mentions":24},{"name":"Medtronic, Inc.","trials":0,"payments":46,"mentions":46},{"name":"Boston Scientific Corporation","trials":0,"payments":3,"mentions":3}]}},"scholarship":{"works_count":187,"cited_by_count":8351,"h_index":51,"i10_index":97,"pubmed_count":14,"latest_activity_year":2026,"source":"works"},"trials":{"count":6,"shown":3,"withheld":3,"matched_by":"identity-adjudicated record","rows":[{"nct":"NCT07523269","title":"WEARABLE-BP: Wearable Everyday Automated Readings to Enable Assessment of Blood Pressure Control","phase":"NA","status":"RECRUITING","role":"Investigator","sponsor":"Aktiia SA","source_url":"https://clinicaltrials.gov/study/NCT07523269","trial_url":"https://www.findmykol.com/trial/NCT07523269"},{"nct":"NCT06297291","title":"Global Paradise System US Post Approval Study","status":"RECRUITING","role":"Investigator","sponsor":"ReCor Medical, Inc.","source_url":"https://clinicaltrials.gov/study/NCT06297291","trial_url":"https://www.findmykol.com/trial/NCT06297291"},{"nct":"NCT05211648","title":"COOL-BP Study: Continuous Versus Occasional Blood Pressure Study","phase":"NA","status":"COMPLETED","role":"Investigator","sponsor":"Aktiia SA","source_url":"https://clinicaltrials.gov/study/NCT05211648","trial_url":"https://www.findmykol.com/trial/NCT05211648"}],"source":"trials"},"payments":{"company_count":7,"program_years":{"first":2021,"last":2025},"rows_total":13,"shown":3,"withheld":10,"rows":[{"payer":"Recor Medical Inc","program_year":2025,"amount_usd":18410.63,"payment_count":17},{"payer":"Boston Scientific Corporation","program_year":2025,"amount_usd":6033.43,"payment_count":3},{"payer":"AstraZeneca UK Limited","program_year":2024,"amount_usd":1611,"payment_count":1}],"source":"payments"},"prescribing":{"data_year":2023,"areas_total":1,"areas_shown":1,"areas":[{"area":"Cardiovascular","share_pct":100,"classes_total":7,"classes":[{"class":"Calcium channel blocker","setting":"prescribed","share_pct":32.3,"drugs":[{"name":"Amlodipine Besylate","share_pct":70.1},{"name":"Felodipine Er","share_pct":29.9}],"max_beneficiaries":null},{"class":"Angiotensin receptor blocker (ARB)","setting":"prescribed","share_pct":21.9,"drugs":[{"name":"Irbesartan","share_pct":76.3},{"name":"Olmesartan Medoxomil","share_pct":23.7}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"office","data_year":2023,"office_pct":100,"facility_pct":0},"source":"medicare"},"funding":{"award_count":6,"fiscal_years":{"first":1998,"last":2012},"rows_total":18,"shown":3,"withheld":15,"rows":[{"project":"R01HL089570","title":"Flavanol-Rich Cocoa, Vascular Responses and Mechanisms","fiscal_year":2012,"amount_usd":581777,"organization":"BRIGHAM AND WOMEN'S HOSPITAL","source_url":"https://reporter.nih.gov/quickSearch/R01HL089570"},{"project":"R01HL089570","title":"Flavanol-Rich Cocoa, Vascular Responses and Mechanisms","fiscal_year":2011,"amount_usd":579112,"organization":"BRIGHAM AND WOMEN'S HOSPITAL","source_url":"https://reporter.nih.gov/quickSearch/R01HL089570"},{"project":"R01HL089570","title":"Flavanol-Rich Cocoa, Vascular Responses and Mechanisms","fiscal_year":2010,"amount_usd":471230,"organization":"BRIGHAM AND WOMEN'S HOSPITAL","source_url":"https://reporter.nih.gov/quickSearch/R01HL089570"}],"source":"grants"},"congress":{"count":8,"years":{"first":2021,"last":2026},"societies":["AHA","ESC","TCT (Transcatheter Cardiovascular Therapeutics)"],"shown":3,"withheld":5,"rows":[{"title":"Endovascular Arena Endovascular Arena 14: Endovascular Denervation — Novel Indications for Novel Locations","society":"TCT (Transcatheter Cardiovascular Therapeutics)","meeting":"TCT (Transcatheter Cardiovascular Therapeutics)","year":2026,"role":"discussant","presentation_type":"unknown","source_url":"https://www.tctconference.com/program","status":"verified"},{"title":"Endovascular Arena Endovascular Arena 1: Clinical Aspects of Performing RDN","society":"TCT (Transcatheter Cardiovascular Therapeutics)","meeting":"TCT (Transcatheter Cardiovascular Therapeutics)","year":2026,"role":"session_chair","presentation_type":"unknown","source_url":"https://www.tctconference.com/program","status":"verified"},{"title":"Endovascular Arena Endovascular Arena 9: Renal Denervation in the Context of the Guidelines (2025 AHA Hypertension Guidelines, Japanese Guidelines, European Guidelines)","society":"TCT (Transcatheter Cardiovascular Therapeutics)","meeting":"TCT (Transcatheter Cardiovascular Therapeutics)","year":2026,"role":"session_chair","presentation_type":"unknown","source_url":"https://www.tctconference.com/program","status":"verified"}],"source":"congress"},"publications":{"total":14,"shown":5,"withheld":9,"matched_by":"ORCID record, linked to PubMed","recent":[{"title":"Evaluating Patients for Renal Denervation: A Pragmatic Approach.","year":2026,"journal":"Hypertension (Dallas, Tex. : 1979)","types":["Journal Article"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/42905791/","status":"verified"},{"title":"Renal Denervation to Treat Hypertension: A Clinical State-of-the-Art Review.","year":2026,"journal":"American journal of hypertension","types":["Journal Article","Review"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/40702973/","status":"verified"},{"title":"Renal denervation for hypertension.","year":2025,"journal":"Nature reviews. Cardiology","types":["Journal Article","Review"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/39743561/","status":"verified"},{"title":"Continual Versus Occasional Blood Pressure (COOL-BP) in Remote Hypertension Management.","year":2025,"journal":"American journal of hypertension","types":["Journal Article","Comparative Study","Research Support, Non-U.S. Gov't","Research Support, N.I.H., Extramural"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/39789184/","status":"verified"},{"title":"The Long-Term Blood Pressure Trends Following a Remote Hypertension Intervention: A Secondary Analysis of the Digital Care Transformation - Remotely Delivered Hypertension Management Program.","year":2025,"journal":"Hypertension (Dallas, Tex. : 1979)","types":["Journal Article","Research Support, N.I.H., Extramural"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/39886769/","status":"verified"}],"most_cited":{"total":187,"shown":5,"withheld":182,"rows":[{"title":"Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial","year":2018,"cited_by_count":734,"type":"article","source_url":"https://doi.org/10.1016/s0140-6736(18)31082-1"},{"title":"Flavanol-rich cocoa induces nitric-oxide-dependent vasodilation in healthy humans","year":2003,"cited_by_count":502,"type":"article","source_url":"https://doi.org/10.1097/00004872-200312000-00016"},{"title":"Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial","year":2021,"cited_by_count":433,"type":"article","source_url":"https://doi.org/10.1016/s0140-6736(21)00788-1"},{"title":"Pathways for Angiotensin II Generation in Intact Human Tissue","year":1998,"cited_by_count":336,"type":"article","source_url":"https://doi.org/10.1161/01.hyp.32.3.387"},{"title":"Plasma 25-Hydroxyvitamin D and Regulation of the Renin-Angiotensin System in Humans","year":2010,"cited_by_count":331,"type":"article","source_url":"https://doi.org/10.1161/hypertensionaha.109.148619"}]},"source":"publications"},"network":{"coauthors_total":40,"shown":3,"withheld":37,"coauthors":[{"name":"Norman K. Hollenberg","coauthored_works":61},{"name":"Benjamin M. Scirica","coauthored_works":28},{"name":"Gordon H. Williams","coauthored_works":28}],"source":"works"},"presence":{"mentions":{"total":3,"shown":3,"rows":[{"url":"https://audioboom.com/posts/7695105","platform":"other","status":"provisional"},{"url":"https://catalyst.harvard.edu/about/all-people/naomi-fisher-md","platform":"other","status":"provisional"},{"url":"https://www.radcliffecardiology.com/authors/naomi-fisher","platform":"other","status":"provisional"}]},"verified_means":"confirmed in more than one place; provisional means found and still being confirmed"},"recognition":{"education":{"total":2,"shown":2,"rows":[{"value":"MD, University of Pennsylvania","source_url":"https://catalyst.harvard.edu/about/all-people/naomi-fisher-md","status":"verified","collected_at":"2026-11-09"},{"value":"Bachelor's degree, Princeton University","source_url":"https://catalyst.harvard.edu/about/all-people/naomi-fisher-md","status":"verified","collected_at":"2026-11-09"}]},"secondary_affiliations":{"total":2,"shown":2,"rows":[{"value":"Harvard Medical School (Associate Professor of Medicine)","source_url":"https://catalyst.harvard.edu/about/all-people/naomi-fisher-md","status":"verified","collected_at":"2026-11-09"},{"value":"Harvard University","status":"verified","collected_at":"2026-11-09"}]},"media":{"total":1,"shown":1,"rows":[{"value":"Understanding food noise - and how to turn down the volume (Harvard Health author page)","source_url":"https://www.health.harvard.edu/authors/naomi-d-l-fisher-md","status":"provisional","collected_at":"2026-11-09"}]}},"similar":[{"name":"Paul Ridker","slug":"paul-ridker","institution":"Brigham and Women's Hospital","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/paul-ridker","json_url":"https://www.findmykol.com/kol/paul-ridker/profile.json"},{"name":"Scott Solomon","slug":"scott-solomon","institution":"Brigham and Women's Hospital","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/scott-solomon","json_url":"https://www.findmykol.com/kol/scott-solomon/profile.json"},{"name":"Marc Pfeffer","slug":"marc-pfeffer","institution":"Brigham and Women's Hospital","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/marc-pfeffer","json_url":"https://www.findmykol.com/kol/marc-pfeffer/profile.json"},{"name":"Reisa Sperling","slug":"reisa-sperling","institution":"Brigham and Women's Hospital","specialty":"Neurology","url":"https://www.findmykol.com/kol/reisa-sperling","json_url":"https://www.findmykol.com/kol/reisa-sperling/profile.json"},{"name":"George Mensah","slug":"george-mensah","institution":"National Heart","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/george-mensah","json_url":"https://www.findmykol.com/kol/george-mensah/profile.json"},{"name":"Edward Giovannucci","slug":"edward-giovannucci","institution":"Harvard T.H. Chan School of Public Health","specialty":"Epidemiology / Public Health","url":"https://www.findmykol.com/kol/edward-giovannucci","json_url":"https://www.findmykol.com/kol/edward-giovannucci/profile.json"},{"name":"Stephen Chanock","slug":"stephen-chanock","institution":"National Cancer Institute (NCI)","specialty":"Epidemiology / Public Health","url":"https://www.findmykol.com/kol/stephen-chanock","json_url":"https://www.findmykol.com/kol/stephen-chanock/profile.json"}],"coverage":{"note":"An identity-adjudicated profile: every section above was checked. Where a section states a count of zero, the public record was searched and nothing was found."},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"trials":3,"payments":10,"funding":15,"congress":5,"publications":9,"network":37}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts","collected_at":"2026-11-09"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies","collected_at":"2026-11-09"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 to 2025","collected_at":"2026-11-09"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2023},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year","collected_at":"2026-11-09"},"congress":{"name":"OpenAlex","url":"https://openalex.org","provides":"DOI-verified congress abstracts across AACR, ASCO, ASH, ASTRO, ESMO","disclaimer":"Congress abstracts are published as DOI-bearing journal supplements and attributed via the same ORCID-disambiguated authorship as publications.","collected_at":"2026-11-09"},"publications":{"name":"PubMed (NLM)","url":"https://pubmed.ncbi.nlm.nih.gov","provides":"Peer-reviewed publications, linked to the PubMed record","collected_at":"2026-11-09"}},"methodology_url":"https://www.findmykol.com/about#methodology"}